HEADER TRANSFERASE 18-FEB-15 4YBK TITLE C-HELIX-OUT DASATINIB ANALOG CRYSTALLIZED WITH C-SRC KINASE COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: UNP RESIDUES 251-533; COMPND 5 SYNONYM: PROTO-ONCOGENE C-SRC,PP60C-SRC,P60-SRC; COMPND 6 EC: 2.7.10.2; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: GALLUS GALLUS; SOURCE 3 ORGANISM_COMMON: CHICKEN; SOURCE 4 ORGANISM_TAXID: 9031; SOURCE 5 GENE: SRC; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET28 KEYWDS PROTEIN KINASE, C-HELIX-OUT, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR F.E.KWARCINSKI,K.B.BRANDVOLD,T.K.JOHNSON,S.PHADKE,J.L.MEAGHER, AUTHOR 2 M.A.SEELIGER,J.A.STUCKEY,M.B.SOELLNER REVDAT 3 27-SEP-23 4YBK 1 REMARK REVDAT 2 01-JUN-16 4YBK 1 JRNL REVDAT 1 02-MAR-16 4YBK 0 JRNL AUTH F.E.KWARCINSKI,K.R.BRANDVOLD,S.PHADKE,O.M.BELEH,T.K.JOHNSON, JRNL AUTH 2 J.L.MEAGHER,M.A.SEELIGER,J.A.STUCKEY,M.B.SOELLNER JRNL TITL CONFORMATION-SELECTIVE ANALOGUES OF DASATINIB REVEAL INSIGHT JRNL TITL 2 INTO KINASE INHIBITOR BINDING AND SELECTIVITY. JRNL REF ACS CHEM.BIOL. V. 11 1296 2016 JRNL REFN ESSN 1554-8937 JRNL PMID 26895387 JRNL DOI 10.1021/ACSCHEMBIO.5B01018 REMARK 2 REMARK 2 RESOLUTION. 2.50 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER-TNT BUSTER 2.10.0 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.50 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 39.62 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 97.1 REMARK 3 NUMBER OF REFLECTIONS : 9952 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.208 REMARK 3 R VALUE (WORKING SET) : 0.206 REMARK 3 FREE R VALUE : 0.252 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.820 REMARK 3 FREE R VALUE TEST SET COUNT : 480 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 5 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.50 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.74 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 97.11 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2567 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.1985 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2433 REMARK 3 BIN R VALUE (WORKING SET) : 0.1926 REMARK 3 BIN FREE R VALUE : 0.2983 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.22 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 134 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2099 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 38 REMARK 3 SOLVENT ATOMS : 51 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 33.47 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 28.06 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -1.09720 REMARK 3 B22 (A**2) : 1.44630 REMARK 3 B33 (A**2) : -0.34910 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.285 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.849 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.293 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.723 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.291 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.905 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.878 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 2221 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 3037 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 1005 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 49 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 358 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 2221 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 271 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 2669 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.008 REMARK 3 BOND ANGLES (DEGREES) : 0.97 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 2.74 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 2.88 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: { A|* } REMARK 3 ORIGIN FOR THE GROUP (A): 57.4575 66.6163 117.9540 REMARK 3 T TENSOR REMARK 3 T11: -0.1549 T22: -0.1170 REMARK 3 T33: -0.1045 T12: -0.0099 REMARK 3 T13: -0.0025 T23: -0.0123 REMARK 3 L TENSOR REMARK 3 L11: 0.6204 L22: 1.0148 REMARK 3 L33: 1.2403 L12: -0.0061 REMARK 3 L13: 0.1476 L23: 0.1729 REMARK 3 S TENSOR REMARK 3 S11: 0.0178 S12: 0.0986 S13: -0.0016 REMARK 3 S21: -0.0750 S22: 0.0141 S23: 0.0090 REMARK 3 S31: -0.0139 S32: -0.0057 S33: -0.0318 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4YBK COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 24-FEB-15. REMARK 100 THE DEPOSITION ID IS D_1000207163. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-AUG-13 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 21-ID-F REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.979 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 225 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 9990 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.500 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 200 DATA REDUNDANCY : 12.90 REMARK 200 R MERGE (I) : 0.13100 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 5.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.50 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.54 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 13.40 REMARK 200 R MERGE FOR SHELL (I) : 0.53800 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 4DGG REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 39.09 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.02 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M MES, PH 6.5, 16% PEG 3350, 420 REMARK 280 MM NAOAC, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 20.66700 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 51.40150 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 31.10650 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 51.40150 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 20.66700 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 31.10650 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 248 REMARK 465 HIS A 249 REMARK 465 MET A 250 REMARK 465 GLN A 251 REMARK 465 THR A 252 REMARK 465 GLN A 253 REMARK 465 GLY A 254 REMARK 465 LEU A 255 REMARK 465 ILE A 411 REMARK 465 GLU A 412 REMARK 465 ASP A 413 REMARK 465 ASN A 414 REMARK 465 GLU A 415 REMARK 465 TYR A 416 REMARK 465 THR A 417 REMARK 465 ALA A 418 REMARK 465 ARG A 419 REMARK 465 GLN A 420 REMARK 465 GLY A 421 REMARK 465 ALA A 422 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 TRP A 260 CG CD1 CD2 NE1 CE2 CE3 CZ2 REMARK 470 TRP A 260 CZ3 CH2 REMARK 470 GLU A 305 CG CD OE1 OE2 REMARK 470 GLN A 309 CG CD OE1 NE2 REMARK 470 LYS A 315 CG CD CE NZ REMARK 470 LYS A 316 CG CD CE NZ REMARK 470 ARG A 318 CG CD NE CZ NH1 NH2 REMARK 470 ARG A 409 CG CD NE CZ NH1 NH2 REMARK 470 GLU A 531 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 THR A 289 -28.06 -154.95 REMARK 500 ARG A 385 -18.47 87.24 REMARK 500 ASP A 386 49.32 -141.26 REMARK 500 REMARK 500 REMARK: NULL REMARK 615 REMARK 615 ZERO OCCUPANCY ATOM REMARK 615 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 615 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 615 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 615 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 615 M RES C SSEQI REMARK 615 4B7 A 601 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 4B7 A 601 DBREF 4YBK A 251 533 UNP P00523 SRC_CHICK 251 533 SEQADV 4YBK GLY A 248 UNP P00523 EXPRESSION TAG SEQADV 4YBK HIS A 249 UNP P00523 EXPRESSION TAG SEQADV 4YBK MET A 250 UNP P00523 EXPRESSION TAG SEQRES 1 A 286 GLY HIS MET GLN THR GLN GLY LEU ALA LYS ASP ALA TRP SEQRES 2 A 286 GLU ILE PRO ARG GLU SER LEU ARG LEU GLU VAL LYS LEU SEQRES 3 A 286 GLY GLN GLY CYS PHE GLY GLU VAL TRP MET GLY THR TRP SEQRES 4 A 286 ASN GLY THR THR ARG VAL ALA ILE LYS THR LEU LYS PRO SEQRES 5 A 286 GLY THR MET SER PRO GLU ALA PHE LEU GLN GLU ALA GLN SEQRES 6 A 286 VAL MET LYS LYS LEU ARG HIS GLU LYS LEU VAL GLN LEU SEQRES 7 A 286 TYR ALA VAL VAL SER GLU GLU PRO ILE TYR ILE VAL THR SEQRES 8 A 286 GLU TYR MET SER LYS GLY SER LEU LEU ASP PHE LEU LYS SEQRES 9 A 286 GLY GLU MET GLY LYS TYR LEU ARG LEU PRO GLN LEU VAL SEQRES 10 A 286 ASP MET ALA ALA GLN ILE ALA SER GLY MET ALA TYR VAL SEQRES 11 A 286 GLU ARG MET ASN TYR VAL HIS ARG ASP LEU ARG ALA ALA SEQRES 12 A 286 ASN ILE LEU VAL GLY GLU ASN LEU VAL CYS LYS VAL ALA SEQRES 13 A 286 ASP PHE GLY LEU ALA ARG LEU ILE GLU ASP ASN GLU TYR SEQRES 14 A 286 THR ALA ARG GLN GLY ALA LYS PHE PRO ILE LYS TRP THR SEQRES 15 A 286 ALA PRO GLU ALA ALA LEU TYR GLY ARG PHE THR ILE LYS SEQRES 16 A 286 SER ASP VAL TRP SER PHE GLY ILE LEU LEU THR GLU LEU SEQRES 17 A 286 THR THR LYS GLY ARG VAL PRO TYR PRO GLY MET VAL ASN SEQRES 18 A 286 ARG GLU VAL LEU ASP GLN VAL GLU ARG GLY TYR ARG MET SEQRES 19 A 286 PRO CYS PRO PRO GLU CYS PRO GLU SER LEU HIS ASP LEU SEQRES 20 A 286 MET CYS GLN CYS TRP ARG LYS ASP PRO GLU GLU ARG PRO SEQRES 21 A 286 THR PHE GLU TYR LEU GLN ALA PHE LEU GLU ASP TYR PHE SEQRES 22 A 286 THR SER THR GLU PRO GLN TYR GLN PRO GLY GLU ASN LEU HET 4B7 A 601 68 HETNAM 4B7 2-({6-[4-(2-HYDROXYETHYL)PIPERAZIN-1-YL]-2- HETNAM 2 4B7 METHYLPYRIMIDIN-4-YL}AMINO)-N-(4-PHENOXYPHENYL)-1,3- HETNAM 3 4B7 THIAZOLE-5-CARBOXAMIDE FORMUL 2 4B7 C27 H29 N7 O3 S FORMUL 3 HOH *51(H2 O) HELIX 1 AA1 PRO A 263 GLU A 265 5 3 HELIX 2 AA2 SER A 303 LYS A 315 1 13 HELIX 3 AA3 LEU A 346 GLY A 352 1 7 HELIX 4 AA4 GLU A 353 TYR A 357 5 5 HELIX 5 AA5 ARG A 359 MET A 380 1 22 HELIX 6 AA6 ARG A 388 ALA A 390 5 3 HELIX 7 AA7 GLU A 396 LEU A 398 5 3 HELIX 8 AA8 PRO A 425 THR A 429 5 5 HELIX 9 AA9 ALA A 430 GLY A 437 1 8 HELIX 10 AB1 THR A 440 THR A 457 1 18 HELIX 11 AB2 VAL A 467 ARG A 477 1 11 HELIX 12 AB3 PRO A 488 TRP A 499 1 12 HELIX 13 AB4 ASP A 502 ARG A 506 5 5 HELIX 14 AB5 THR A 508 THR A 523 1 16 SHEET 1 AA1 5 LEU A 267 GLN A 275 0 SHEET 2 AA1 5 GLY A 279 TRP A 286 -1 O MET A 283 N VAL A 271 SHEET 3 AA1 5 THR A 290 LEU A 297 -1 O THR A 296 N GLU A 280 SHEET 4 AA1 5 ILE A 334 GLU A 339 -1 O ILE A 336 N LYS A 295 SHEET 5 AA1 5 LEU A 325 VAL A 329 -1 N TYR A 326 O VAL A 337 SHEET 1 AA2 3 GLY A 344 SER A 345 0 SHEET 2 AA2 3 ILE A 392 VAL A 394 -1 O VAL A 394 N GLY A 344 SHEET 3 AA2 3 CYS A 400 VAL A 402 -1 O LYS A 401 N LEU A 393 CISPEP 1 GLU A 332 PRO A 333 0 0.55 SITE 1 AC1 14 LEU A 273 VAL A 281 ALA A 293 LYS A 295 SITE 2 AC1 14 ILE A 336 THR A 338 GLU A 339 TYR A 340 SITE 3 AC1 14 MET A 341 SER A 342 GLY A 344 LEU A 393 SITE 4 AC1 14 ASP A 404 PHE A 405 CRYST1 41.334 62.213 102.803 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.024193 0.000000 0.000000 0.00000 SCALE2 0.000000 0.016074 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009727 0.00000